𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Do selective COX-2 inhibitors increase the risk of cerebrovascular events? A meta-analysis of randomized controlled trials

✍ Scribed by L-C. Chen; D. M. Ashcroft


Book ID
108848985
Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
606 KB
Volume
31
Category
Article
ISSN
0269-4727

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Do adjuvant aromatase inhibitors increas
✍ Federica Cuppone; Emilio Bria; Sunil Verma; Kathleen I. Pritchard; Sonal Gandhi; πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 203 KB πŸ‘ 1 views

## Abstract ## BACKGROUND. Despite the advantages from using aromatase inhibitors (AIs) compared with tamoxifen for early breast cancer, an unexpectedly greater number of grade 3 and 4 cardiovascular events (CVAE) (as defined by National Cancer Institute of Canada‐Common Toxicity Criteria [version